Physostigmine for cardiac and neurologic manifestations of phenothiazine poisoning.
Psychotropic drugs such as the phenothiazine neuroleptics and tricyclic antidepressants are known to cause electrocardiographic abnormalities as well as a central anticholinergic syndrome. Physostigmine is known to reverse the central muscarinic anticholinergic manifestations by inhibition of the enzyme cholinesterase. An unusual case of trifluoperazine overdose, in which the patient presented with cardiac arrhythmias and a central anticholinergic syndrome, is presented. Treatment with physostigmine reversed the central anticholinergic syndrome as well as the electrocardiographic abnormalities. Effects of phenothiazines on altering cardiac status are also discussed.
D014150:Antipsychotic Agents / Q000506:poisoning*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D004562:Electrocardiography; D006801:Humans; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced / Q000188:drug therapy*; D010276:Parasympatholytics / Q000506:poisoning; D010830:Physostigmine / Q000627:therapeutic use*; D014268:Trifluoperazine / Q000506:poisoning
D014150:Antipsychotic Agents; D010276:Parasympatholytics; D014268:Trifluoperazine; D010830:Physostigmine